Zevra Therapeutics
ZVRA
ZVRA
120 hedge funds and large institutions have $319M invested in Zevra Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.64% more ownership
Funds ownership: 65.55% → 66.19% (+0.64%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
14% less call options, than puts
Call options by funds: $5.01M | Put options by funds: $5.81M
Holders
120
Holding in Top 10
5
Calls
$5.01M
Puts
$5.81M
Top Buyers
| 1 | +$6.01M | |
| 2 | +$4.46M | |
| 3 | +$4.27M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$3.65M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$2.56M |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$4.21M | |
| 3 | -$3.1M | |
| 4 |
Barclays
London,
United Kingdom
|
-$2.68M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.09M |